Menu Search
Equities

Kontigo Care AB

3KT:FRA

Kontigo Care AB

Actions
  • Price (EUR)0.1795
  • Today's Change-0.018 / -9.11%
  • Shares traded--
  • 1 Year change+4.36%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kontigo Care AB is a Sweden-based company, which is primarily focused on advanced medical equipment industry. The Company operates as a provider of mobile solutions for the treatment of alcoholism. The Company develops TripleA which is a system of care for the treatment of alcoholism. The system consists of a wireless breathalyzer, an application and a health care portal. The portal creates patient care plan and shares it with health care provider. On the basis of this plan, the patient receives information about scheduled sobriety test. Test results are then sent back to the health care provider who can monitor the patient's sobriety every day. The Company operates domestically on the territory of Sweden.

  • Revenue in SEK (TTM)30.11m
  • Net income in SEK990.00k
  • Incorporated2013
  • Employees10.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.